Fresenius Medical Care AG & Co. KGaA (FMEA) — Cash Flow Reinvestment Rate
Fresenius Medical Care AG & Co. KGaA (FMEA) has a Cash Flow Reinvestment Rate of 0.93x as of March 2026, reinvesting €210.71 Million (capex €190.07 Million plus investments €20.64 Million) from operating cash flow of €226.89 Million. See Fresenius Medical Care AG & Co. KGaA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Fresenius Medical Care AG & Co. KGaA Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Fresenius Medical Care AG & Co. KGaA across 10 annual periods. For the full cash flow conversion analysis, see Fresenius Medical Care AG & Co. KGaA cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Fresenius Medical Care AG & Co. KGaA (2016–2025)
Year-by-year capital reinvestment analysis for Fresenius Medical Care AG & Co. KGaA. See FMEA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | €919.39 Million | €2.68 Billion | €915.37 Million | ▲ +15.9% |
| 2024 | 0.30x | €705.73 Million | €2.39 Billion | €699.36 Million | ▼ -36.7% |
| 2023 | 0.47x | €1.23 Billion | €2.63 Billion | €684.60 Million | ▲ +27.4% |
| 2022 | 0.37x | €795.27 Million | €2.17 Billion | €723.99 Million | ▼ -0.3% |
| 2021 | 0.37x | €915.93 Million | €2.49 Billion | €854.36 Million | ▲ +39.4% |
| 2020 | 0.26x | €1.12 Billion | €4.23 Billion | €1.05 Billion | ▼ -40.7% |
| 2019 | 0.45x | €1.14 Billion | €2.57 Billion | €1.12 Billion | ▼ -38.7% |
| 2018 | 0.73x | €1.50 Billion | €2.06 Billion | €1.06 Billion | ▲ +34.6% |
| 2017 | 0.54x | €1.18 Billion | €2.19 Billion | €944.46 Million | ▼ -54.5% |
| 2016 | 1.19x | €2.29 Billion | €1.93 Billion | €979.36 Million | — |